0B68 Pestell, Richard G. - Thomas Jefferson University - Thomas Jefferson University
rpg102

Richard G. Pestell, MD, PhD

Contact Dr. Pestell

Kimmel Cancer Center
233 S. Tenth Street, Suite 1050
Philadelphia, PA 19107

(215) 503-5692
(215) 503-9334 fax

Most Recent Peer-reviewed Publications

  1. Cyclin D1 integrates estrogen-mediated DNA damage repair signaling
  2. CAPER, a novel regulator of human breast cancer progression
  3. Overview of cyclins D1 function in cancer and the CDK inhibitor landscape: Past and present
  4. Long and noncoding RNAs (lnc-RNAs) determine androgen receptor dependent gene expression in prostate cancer growth in vivo
  5. Cell fate factor DACH1 represses YB-1-mediated oncogenic transcription and translation
  6. Identification of a cyclin D1 network in prostate cancer that antagonizes epithelial-mesenchymal restraint
  7. The metastatic potential of triple-negative breast cancer is decreased via caloric restriction-mediated reduction of the miR-17~92 cluster
  8. miR-17/20 sensitization of breast cancer cells to chemotherapy-induced apoptosis requires Akt1
  9. MiR-221/222 promotes S-Phase entry and cellular migration in control of basal-like breast cancer
  10. Cyclin D1 induction of dicer governs microRNA processing and expression in breast cancer
  11. MicroRNAs and cancer stem cells: the sword and the shield
  12. Stromal glycolysis and MCT4 are hallmarks of DCIS progression to invasive breast cancer
  13. Cyclin D1 determines estrogen signaling in the mammary gland in vivo
  14. Oncogenes and inflammation rewire host energy metabolism in the tumor microenvironment RAS and NFκB target stromal MCT4
  15. Reverse warburg effect in a patient with aggressive B-cell lymphoma: Is lactic acidosis a paraneoplastic syndrome?
  16. Cancer cell proliferation through cyclin D1
  17. Erratum: Regulation of the androgen receptor by SET9-mediated methylation (Nucleic Acids Research (2011) 39 (1266-1279) DOI:10.1093/nar/gkq861)
  18. New roles of cyclin D1
  19. Caloric restriction augments radiation efficacy in breast cancer
  20. Acetylation of the cell-fate factor dachshund determines p53 binding and signaling modules in breast cancer
0